Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DiaPep277 in Type 1 Diabetes
NCT01881958Phase 2Withdrawn
- Sponsor
- Hadassah Medical Organization
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Peptides, Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of diapep277 in type 1 diabetes mellitus (T1D), sponsored by Hadassah Medical Organization. Primary endpoint: Hemoglobin A1c at 2 years. Planned start Jan 2015; status: withdrawn.
02
Drugs
diapep277
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01881958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01881958.